Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Dr Jane Deayton

Back to Search
Deayton J, O'Sullivan E, McKnight A, Groves K, Bibby D, Clark D, Orkin C, Reeves I et al. ( 2015 ) . Disease progression in HIV-1 controllers; uptake and outcome of antiretroviral therapy . HIV MEDICINE vol. 16 , 20 - 20 .
Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M et al. ( 2013 ) . HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient sub-groups . Antivir Ther
Elamin W, Bibby D, Clark D, Anderson J, Deayton J ( 2013 ) . HIV-2 in the United Kingdom - the North-East London cohort . HIV MEDICINE vol. 14 , 53 - 53 .
Groves KC, Bibby DF, Clark DA, Isaksen A, Deayton JR, Anderson J, Orkin C, Stagg AJ et al. ( 2012 ) . Disease Progression in HIV-1-Infected Viremic Controllers . J Acquir Immune Defic Syndr vol. 61 , ( 4 ) 407 - 416 .
Peterson K, Ruelle J, Vekemans M, Siegal FP, Deayton JR, Colebunders R ( 2012 ) . The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series . Antivir Ther vol. 17 , ( 6 ) 1097 - 1100 .
Groves K, Bibby D, Clark D, Isaksen A, Deayton J, Anderson J, Orkin C, Stagg AJ et al. ( 2010 ) . Disease Progression Despite Suppressed Plasma Viral Load in Human Immunodeficiency Infected Viremic Controllers . AIDS RESEARCH AND HUMAN RETROVIRUSES . vol. 26 , A163 - A163 .
Dhairyawan R, Hutchinson J, Deayton J, Estcourt C ( 2010 ) . Educating East London primary care providers to improve rates of HIV testing and HIV recognition in an area of high HIV prevalence and late presentation .
Deayton J, Clark D, Bibby D ( 2010 ) . HIV-2 viral load testing - validation and quantification at low copy number .
Deayton J, Bibby D, Orkin C, O'Sullivan E, McKnight A, Clark D ( 2010 ) . Inter-clade dual HIV-1 infection in the UK - an emerging phenomenon .
Hogan S, DeSouza C, Deayton J ( 2010 ) . Lymphopenia on routine full blood count as an indicator of undiagnosed HIV infection .
Deayton JR, Thorpe JW ( 2010 ) . Neurological Complications of HIV Infection and AIDS . Treatment Strategies - AIDS vol. The Cambridge Resear , 121 - 126 .
Groves KC, Bibby D, Isaksen A, Deayton J, Anderson J, Orkin C, Stagg AJ, McKnight A ( 2009 ) . Altered T cell homeostasis and activation in HIV-1 elite suppressors with low CD4+T-cell counts . RETROVIROLOGY vol. 6 , Article P250 ,
Thorpe JW, Deayton JR ( 2009 ) . Neurological Complications of HIV . Medicine ( 37 ) 352 - 356 .
Waters LJ, Dave SS, Deayton JR, French PD ( 2005 ) . Recalcitrant Trichomonas vaginalis infection--a case series . Int J STD AIDS vol. 16 , ( 7 ) 505 - 509 .
Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD ( 2004 ) . Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy . Lancet vol. 363 , ( 9427 ) 2116 - 2121 .
Deayton JR, Sabin CA, Britt WB, Jones IM, Wilson P, Johnson MA, Griffiths PD, Emery VC ( 2002 ) . Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy . AIDS vol. 16 , ( 16 ) 2129 - 2135 .
Deayton JR ( 2001 ) . Changing trends in cytomegalovirus disease in HIV-infected patients . Herpes vol. 8 , ( 2 ) 37 - 40 .
Worrell S, Deayton J, Hayes P, Emery VC, Gotch F, Gazzard B, Larsson-Sciard EL ( 2001 ) . Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication . HIV Med vol. 2 , ( 1 ) 11 - 19 .
Deayton JR, Sabin CA, Johnson MA, Griffiths PD, Emery VC ( 2000 ) . Efficacy of the regenerating immune system in the inhibition of CMV replication after highly active antiretroviral therapy (HAART)) . AIDS vol. 14 , S5 - S5 .
Deayton JR, Shannon-Lowe C, Wilson P, Johnson MA, Griffiths PD, Emery VC ( 2000 ) . Recurrence of CMV viraemia and development of anti-CMV drug resistance in patients receiving highly active antiretroviral therapy after CMV retinitis .
Back to Search